Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in southern Tanzania

Journal of Medical Virology

Volumn 58, Issue 3, 1999, Pages 215-220

  Menendez, Clara ^a   Sanchez Tapias, Jose Maria ^a   Kahigwa, Elizeus ^b   Mshinda, Hassan ^c   Costa, Josep ^a   Vidal, Josep ^a   Acosta, Camilo ^a,c   Lopez Labrador, Xavier ^a   Olmedo, Eva ^a   Navia, Margarita ^a   Tanner, Marcel ^d   Rodes, Joan ^a   Alonso, Pedro Luis ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b St Francis Designated District Hospital   (Tanzania)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Africa; Maternal; Vertical transmission; Viral hepatitis

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; SEROLOGY; TANZANIA; VERTICAL TRANSMISSION; VIRUS DETECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS E; HEPATITIS, VIRAL, HUMAN; HUMANS; INFANT; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RNA, VIRAL; TANZANIA;

EID: 0033039255     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K     Document Type: Article

References (44)

1. Alter MJ, Hadler SC, Judaon FN, Mares A, Alexander WJ, Hu PY, Miller JK, Moyer LA, Fields HA, Bradley DW, Margolis HS. 1990. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C infection. JAMA 264:2231-2235.
2. Alter MJ, Margolis HS, Krawezynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks L, Beach MJ. 1992. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905.
3. Arthur RR, Hassan NF, Abdallah MY, el Sharkawy MS, Saad MD, Hackbart BG, Imam IZ. 1997. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans Royal Soc Tropic Med Hygiene 91:271-274.
4. Ayoola EA. 1988. Viral hepatitis in Africa. In Zuckerman AJ, editor. Viral hepatitis and liver disease. New York: AR Liss, Inc., p 161-169.
5. Bowry TR. 1983. Seroepidemiology of hepatitis B in an urban population of Nairobi, Kenya. J Inf Dis 148:1122.
6. Chen DS, Hsu HM, Bennett CL, Pajeau TS, Blumberg B, Chang PY, Nishioka K, Huang A, Sung JL. 1996. A program for eradication of hepatitis B from Taiwan by a 10 year, four dose vaccination program. Cancer Causes Control 7:305-311.
7. Coursaget P, Chiron JP, Barres JL, Barin F, Cottey P, Tortey E, Yvonnet B, Diop B, Mboup S, Diop Mar I. 1984. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma. IARC Sci Pub 63:181-198.
8. Coursaget P, Leboulleux D, Gharbi Y, Enogat N, Ndao MA, Coll Seek AM, Kastally R. 1995. Etiology of acute sporadic hepatitis in adults in Senegal and Tunisia. Scand J Inf Dis 27:9-11.
9. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follet EA, Seed CR, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Yap PL. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 76:1197-1204.
10. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. 1988. Hepatocellular carcinoma. Ann Int Med 108:390-401.
11. Dow BC, Munro H, Buchanan I, Follet EA, Davidson F, Yap PL, Simmonds P. 1996. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype. Transfusion 36:547-551.
12. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. 1996. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Inf 117:313-325.
13. Goudeau A, Yvonnet B, Lesage G, Barin F, Denis F, Coursaget P, Chiron JP, Diop Mar I. 1983. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet 2:1103-1104.
14. Hall AJ. 1996. Viral hepatitis: control, seroepidemiology and surveillance. Trans Royal Soc Tropic Med Hygiene 90:1-2.
15. Harry TO, Bajani MD, Moses AE. 1994. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. E Africa Med J 71:596-597.
16. Hassan NF, Kotkat A. 1993. Prevalence of antibodies to hepatitis C virus infection in pregnant women in Egypt. J Inf Dis 168:248-249.
17. Hyams KC, Osman NM, Khaled EM, Koran el-Wahab AA, Imam IZ, el-Ghorab NM, Dunn MA, Woody SN. 1988. Maternal-infant transmission of Hepatitis B in Egypt. In AJ Zuckerman, editor. Viral hepatitis and liver disease. New York: A.R. Liss, Inc., p 170-173.
18. Lin HH, Hsu HY, Lee TY, Hsieh RP, Chen PJ, Chen DS. 1994. Age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Asia Oceania J Obstetr Gynaecol 20: 141-145.
19. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F, Acosta CJ, Schellenberg DM, Galindo CM, Kimario J, Urassa H, Brabin B, Smith TA, Kitua AY, Tanner M, Alonso PL. 1997. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350:844-850.
20. Mwakagile D, Swai AB, Sandstrom E, Urassa E, Biberfeld G, Mhalu FS. 1996. High frequency of sexually transmitted diseases among pregnant women in Dar es Salaam, Tanzania: need for intervention. E Africa Med J 73:675-678.
21. Ndumbe PM, Andela A, Nkemnkeng Asong J, Watonsi E, Nyambi P. 1992. Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon. Med Microbiol Immunol (Berlin) 181:127-130.
22. Ndumbe PM, Skalsky J. 1993. Hepatitis C virus infection in different populations in Cameroon. Scand J Inf Dis 25:689-692.
23. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S. 1994. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 330:744-750.
24. Olmedo E, Costa J, Lopez-Labrador FX, Forns X, Ampurdanes S, Maluenda M, Guilera M, Sanchez-Tapias JM, Rodes J, Jimenez de Anta MT. 1999. Comparative study of a modified competitive RT-PCR and amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum. J Med Virol 58:35-43.
25. Oni AO, Harrison TJ. 1996. Genotypes of hepatitis C virus in Nigeria. J Med Virol 49:178-186.
26. Pellizzer G, Ble C, Zamperetti N, Stroffolini T, Upunda G, Rapicetta M, Chionne P, Villano U, Fabris P, de Lalla F. 1994. Serological survey of hepatitis B infection in Tanzania. Pub Health 108:427-431.
27. Petry KU, Kingu H. 1996. HIV infection among pregnant women in Lindi, Tanzania, 1989-1993, Int J STD AIDS 7:265-268.
28. Pujol FH, Favorov MO, Marcano T, Este JA, Magris M, Liprandi F, Khudyakov YE, Khudiakova NS, Fields HA. 1994. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol 42:234-236.
29. Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, Essex M. 1993. Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 6:65-73.
30. Ruggieri A, Argentini C, Kouruma F, Chionne P, D'Ugo E, Spada E, Dettori S, Sabbatani S, Rapicetta. 1996. Heterogeneity of hepatitis C virus genotype 2 variants in west central Africa (Guinea Conakry). J Gen Virol 77:2073-2076.
31. Sabatino G, Ramenghi LA, di-Marzio M, Pizzigallo E. 1996. Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. Eur J Epidemiol 12:443-447.
32. Salleras L, Bruguera M, Vidal J, Plans P, Dominguez A, Salleras M, Navas E, Gali N. 1994. The seroepidemiology of hepatitis C virus infection in pregnant women in Catalonia. Med Clin (Barcelona) 103:721-724.
33. Schoub BD, Johnson S, McAnerey JM, Blackburn NK. 1992. The role of sexual transmission in the epidemiology of hepatitis C virus in Black South Africans. Trans Royal Soc Tropic Med Hygiene 86: 431-433.
34. Skidmore SJ. 1997. Tropical aspects of viral hepatitis: hepatitis E. Trans Royal Soc Tropic Med Hygiene 90:1-2.
35. Smuts HE, Kannemeyer J. 1995. Genotyping of hepatitis C virus in South Africa. J Clin Microbiol 33:1679-1681.
36. Stahel E, Tanner M, Gyr N, Weiss N, Hess C, Betschart B. 1984. Seroepidemiology of hepatitis B virus in rural Tanzania: relation of hepatitis B markers and liver function tests in patients with clinical liver disease and healthy controls. E Africa Med J 61:806-811.
37. Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. 1998. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 27:108-117.
38. Tibbs CJ, Palmer SJ, Coker R, Clark SK, Parsons GM, Hojvat S, Peterson D, Banatvala JE. 1991. Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays. J Med Virol 34:143-147.
39. Tibbs CJ. 1997. Tropical aspects of viral hepatitis. Trans Royal Soc Tropic Med Hygiene 91:121-124.
40. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bougherra A, Hmida S, Dhahri R, Dellagi K. 1997. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans Royal Soc Tropic Med Hygiene 91:11-14.
41. Whittle HC, Bradley AK, McLauchan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA. 1983. Hepatitis B infection in two Gambian villages. Lancet i:1203-1206.
42. Xu LZ, Larzul D, Delaporte E, Brechot C, Kremsdorf D. 1994. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol 75:2393-2397.
43. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D'Amico E, Cambie G, Veccchi L. 1995. Mother-to-infant transmission of hepatitis C virus. Lancet 345:289-291.
44. Zein NN, Germer JJ, Wendt NK, Schimek CM, Thorvilson JN, Mitchell PS, Persing DH. 1997. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J Clin Microbiol 35:311-312.